Enanta Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Good morning, everyone. I hope you're enjoying day one of our Jefferies Healthcare Conference. For those who don't know me, my name is Akash Tewari, I'm one of the biotech analysts here. I have the pleasure of hosting the Enanta management team. Why don't I hand it off to Jay and Tara to give some brief introductions and then we'll get into some Q&A.
Sure. Before we begin, I want to remind you that I'll be making some forward-looking statements today. For a summary of the risks associated with these statements, please see our filings on sec.gov and on our website. So I'm Jay Luly, I'm President and CEO of Enanta. I'm sorry, Akash, you just wanted to do name introduction.
I mean, if you want to give any introductory remarks sure, but otherwise we can get into Q&A.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |